Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]

Dual-targeted antibody mosunetuzumab elicits durable responses in poor...

Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA

Dual-targeted antibody mosunetuzumab elicits durable responses in poor-prognosis non-Hodgkin Lymphoma patients ( Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA )

Multiple myeloma patients treated with BCMA-directed CAR T-cell therapy have...

Prof Deepu Madduri - Mount Sinai, New York, USA

Multiple myeloma patients treated with BCMA-directed CAR T-cell therapy have high response rate ( Prof Deepu Madduri - Mount Sinai, New York, USA )

Cellular immunotherapy for B cell cancers shows promise

Dr Bahram Valamehr - Fate Therapeutics Inc., San Diego, USA

Cellular immunotherapy for B cell cancers shows promise ( Dr Bahram Valamehr - Fate Therapeutics Inc., San Diego, USA )

The importance of proper geriatric classification for haematological...

Dr Raúl Cordoba - Jiménez Diaz Foundation University Hospital, Madrid, Spain

The importance of proper geriatric classification for haematological malignancies ( Dr Raúl Cordoba - Jiménez Diaz Foundation University Hospital, Madrid, Spain )

APAO: Providing support and opportunities for PAs

Jeremy Heinerich PA-C, DFAAPA - APAO Past President

APAO: Providing support and opportunities for PAs ( Jeremy Heinerich PA-C, DFAAPA - APAO Past President )

Advice for bone marrow biopsies and lumber punctures

Dwight Macero PA-C - University of Colorado, Denver, USA

Advice for bone marrow biopsies and lumber punctures ( Dwight Macero PA-C - University of Colorado, Denver, USA )

The latest research highlights in lymphoma

Corinne Williams, PA-C, President of APAO

The latest research highlights in lymphoma ( Corinne Williams, PA-C, President of APAO )

Ensuring high quality PA education programmes

Bruce Christensen PA-C - UT Health Science Center San Antonio, San Antonio, USA

Ensuring high quality PA education programmes ( Bruce Christensen PA-C - UT Health Science Center San Antonio, San Antonio, USA )

Real-world use of carfilzomib in relapsed multiple myeloma patients with pre...

Dr Jo Caers - Centre Hospitalier Universitaire de Liège, Liège, Belgium

Real-world use of carfilzomib in relapsed multiple myeloma patients with pre-existing cardiovascular comorbidities ( Dr Jo Caers - Centre Hospitalier Universitaire de Liège, Liège, Belgium )

D-VTd in transplant-eligible newly diagnosed MM: Subgroup analysis of high-risk...

Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands

D-VTd in transplant-eligible newly diagnosed MM: Subgroup analysis of high-risk patients in CASSIOPEIA ( Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands )

Adding daratumumab to existing multiple myeloma regimen of lenalidomide...

Prof Peter Voorhees - Levine Cancer Institute, Charlotte, USA

Adding daratumumab to existing multiple myeloma regimen of lenalidomide, bortezomib and dexamethasone ( Prof Peter Voorhees - Levine Cancer Institute, Charlotte, USA )

A phase 1b study of once-weekly KRd in patients with newly diagnosed multiple...

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA

A phase 1b study of once-weekly KRd in patients with newly diagnosed multiple myeloma ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )

More from ecancer